Imunon Inc has a consensus price target of $13.5, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on May 14, 2024, April 1, 2024, and March 13, 2024. With an average price target of $12.33 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 839.90% upside for Imunon Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/14/2024 | Buy Now | 814.49% | HC Wainwright & Co. | Emily Bodnar | $13 → $12 | Maintains | Buy | Get Alert |
04/01/2024 | Buy Now | 890.7% | HC Wainwright & Co. | Emily Bodnar | $12 → $13 | Maintains | Buy | Get Alert |
03/13/2024 | Buy Now | 814.49% | HC Wainwright & Co. | Emily Bodnar | → $12 | Reiterates | Buy → Buy | Get Alert |
09/15/2023 | Buy Now | 814.49% | HC Wainwright & Co. | Emily Bodnar | → $12 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | Buy Now | 814.49% | HC Wainwright & Co. | Emily Bodnar | → $12 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 814.49% | HC Wainwright & Co. | Emily Bodnar | → $12 | Reiterates | → Buy | Get Alert |
10/13/2022 | Buy Now | 1043.12% | Alliance Global Partners | James Molloy | → $15 | Initiates | → Buy | Get Alert |
The latest price target for Imunon (NASDAQ: IMNN) was reported by HC Wainwright & Co. on May 14, 2024. The analyst firm set a price target for $12.00 expecting IMNN to rise to within 12 months (a possible 814.49% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Imunon (NASDAQ: IMNN) was provided by HC Wainwright & Co., and Imunon maintained their buy rating.
There is no last upgrade for Imunon.
There is no last downgrade for Imunon.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Imunon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Imunon was filed on May 14, 2024 so you should expect the next rating to be made available sometime around May 14, 2025.
While ratings are subjective and will change, the latest Imunon (IMNN) rating was a maintained with a price target of $13.00 to $12.00. The current price Imunon (IMNN) is trading at is $1.31, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.